As one of the leading facilities for advanced neurological and Parkinson’s care in the region, King’s College Hospital Dubai ...

Two studies published in Nature found stem-cell derived products can not only be safely transplanted into the brain, but also ...

SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases total daily ON time vs placebo.

For patients with Parkinson's disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist ...

Oral carbidopa-levodopa formulation improves sleep in Parkinson disease, particularly addressing sleep disturbances and ...

Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.

A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with depression who experience motivational impairments ...

SUNRISE-PD evaluating the Company's anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson's disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one ...

Get Instant Summarized Text (Gist) Levodopa, a dopamine-enhancing medication, may improve motivation in depression linked to high inflammation. Individuals with C-reactive protein (CRP) levels ...